Palisade Bio Inc (PALI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2025 | 09-2025 | 06-2025 | 03-2025 | 12-2024 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -16,781 | -7,882 | -5,014 | -2,230 | -14,438 |
| Depreciation Amortization | 3 | 3 | 2 | 1 | 3 |
| Other Working Capital | 1,639 | -473 | 596 | -203 | 1,391 |
| Other Operating Activity | 4,292 | 649 | 266 | 99 | 851 |
| Operating Cash Flow | $-10,847 | $-7,703 | $-4,150 | $-2,333 | $-12,193 |
| Cash Flows From Investing Activities | |||||
| Investing Cash Flow | $N/A | $N/A | $N/A | $N/A | $N/A |
| Cash Flows From Financing Activities | |||||
| Debt Repayment | -320 | -180 | -80 | -80 | -426 |
| Common Stock Issued | 128,238 | 3,912 | 4 | N/A | 8,446 |
| Common Stock Repurchased | 7,635 | N/A | N/A | N/A | 2,506 |
| Other Financing Activity | -1,113 | -623 | -178 | -178 | -944 |
| Financing Cash Flow | $134,440 | $3,109 | $-254 | $-258 | $9,582 |
| Beginning Cash Position | 9,847 | 9,847 | 9,847 | 9,847 | 12,458 |
| End Cash Position | 133,440 | 5,253 | 5,443 | 7,256 | 9,847 |
| Net Cash Flow | $123,593 | $-4,594 | $-4,404 | $-2,591 | $-2,611 |
| Free Cash Flow | |||||
| Operating Cash Flow | -10,847 | -7,703 | -4,150 | -2,333 | -12,193 |
| Free Cash Flow | -10,847 | -7,703 | -4,150 | -2,333 | -12,193 |